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Collaborating With Pediatric Gastroenterologists to Treat Co-Occurring
Inflammatory Bowel Disease and Anxiety in Pediatric Medical Settings
Laura C. Reigada, Amanda McGovern, Megan E. Tudor, and
Deborah J. Walder, Brooklyn College of the City University of New York
Carrie Masia Warner, William Paterson University, Nathan S. Kline Institute for Psychiatric Research,
NYU Langone Medical Center
Children and adolescents with inflammatory bowel disease (IBD) have distinct physical and emotional challenges that may place them at
risk for developing anxiety and that may impede their receipt of mental health treatment. Only a handful of studies have applied empirically
validated cognitive behavioral therapy (CBT) to IBD-related issues and no studies have examined the benefit of CBT for anxiety disorders in
pediatric IBD. The aim of this paper is to describe a newly adapted cognitive behavioral treatment protocol, Treatment of Anxiety and
Physical Symptoms related to IBD (TAPS + IBD), that has been tailored to concurrently address anxiety, including IBD-specific anxiety,
and disease management in children and adolescents with IBD in pediatric medical offices. Two case studies are presented to demonstrate
treatment implementation and preliminary assessment data. General considerations for health providers working with youth with comorbid
anxiety and IBD from a multidisciplinary perspective and future research directions are provided.

T

HERE is emerging interdisciplinary appreciation of the
importance of considering physical and emotional
comorbidity when conceptualizing illness presentation and
determining course of treatment. Accordingly, researchers
have begun to focus efforts aimed at: (a) enhancing early
identification of medical patients who are at increased risk
for comorbid anxiety, including illness-specific anxiety;
(b) developing empirically validated, multidisciplinary
treatments targeting both illness-specific and general
psychiatric symptoms; and (c) evaluating the utility and
efficiency (both in terms of health benefits and economic
gains) of cross-disciplinary approaches within a single
setting—the medical setting.
However, relatively scant attention has been focused on
these issues among children and adolescents diagnosed with
inflammatory bowel disease (IBD), a chronic autoimmune
disorder that consists of Crohn’s disease and ulcerative
colitis. In this paper, we will provide a brief overview of
anxiety in youth diagnosed with IBD and current treatment
models. Next, we describe in detail a newly adapted cognitive
behavioral treatment protocol, Treatment of Anxiety and
Physical Symptoms related to IBD (TAPS + IBD), that targets
anxiety and disease management, with an emphasis on the
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integration of mental health services and medical care
specifically within a pediatric specialty practice. This program
aims to (a) enhance early identification of young medical
patients at increased risk for comorbid anxiety, including
illness-specific anxiety; (b) augment the potential benefit of a
health-integrative CBT approach in treating comorbid
anxiety among youth with IBD; and (c) offer a model by
which to test the feasibility of a multidisciplinary approach for
the assessment and treatment of comorbid anxiety among
youth with IBD within the medical setting. Two clinical cases
from a larger ongoing research program are provided to
illustrate the practical application of the TAPS + IBD
approach within a medical setting. Finally, we provide
general considerations for health providers working with
youth with comorbid anxiety and IBD from a multidisciplinary perspective, and offer suggestions for future directions.

Anxiety in Youth With IBD
Children and adolescents diagnosed with IBD are at
heightened risk for anxiety symptoms (Kilroy, Nolan, &
Sarma, 2011; Reigada et al., 2011) and anxiety disorders
(Mackner, Crandall, & Szigethy, 2006; Szajnberg, Krall,
Davis, Treem, & Hyams 1993). Limited by methodological
issues, estimates of rates of anxiety disorders among
children with IBD remain unclear. Cumulatively, reports
suggest that children with IBD are more likely to meet
criteria for a psychiatric anxiety diagnosis than healthy
children without a medical illness (Mackner & Crandall,
2007). One large nationwide retrospective study found
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that youth with Crohn’s disease were two to three times
more likely to meet diagnostic criteria for an anxiety
disorder than community controls (Loftus et al., 2011). A
handful of small studies using validated diagnostic
interviews suggest that generalized anxiety, social anxiety,
separation anxiety, and simple phobias are common
anxiety disorders among youth with IBD (Burke et al.,
1989; Engstrom & Lindquist, 1991; Reigada et al., 2013;
Szajnberg et al., 1993).
In addition to established clinical anxiety disorders,
youth with IBD also may be vulnerable to developing
debilitating IBD-specific anxiety symptoms. IBD-specific
anxiety consists of disproportionately intense worries, or
unrealistic overestimations of negative outcomes, surrounding the reoccurrence and implication of physical symptoms, treatment, and medical procedures (Casati, Toner,
de Rooy, Drossman, & Maunder, 2000; Dorrian, Dempster,
& Adair, 2009). Youth with IBD may be particularly
susceptible to developing disease-specific fears given the
unpredictable nature of IBD along with perceived embarrassing gastrointestinal symptoms, such as abdominal pain,
nausea, diarrhea, and rectal bleeding. Unlike other chronic
medical illnesses, there is little public awareness of IBD,
rendering this medical condition and its accompanying
symptoms particularly stigmatizing and isolating.

The Impact of Comorbid Anxiety and IBD
Anxiety can be detrimental for youth diagnosed with IBD.
Anxiety symptoms can lower one’s ability to cope with
physical symptoms, lead to greater functional impairment,
and decrease quality of life (Casati et al., 2000; Mackner et al.,
2006; Moody, Eaden, & Mayberry, 1999; Rabbett et al., 1996).
Moreover, the physiological and behavioral changes associated with anxiety are linked with worse disease course and
symptom relapse in patients with IBD (Cohen, Janicki-Deverts, & Miller, 2007; Segerstrom & Miller, 2004). Anxiety can
also complicate medical treatment indirectly. For example,
anxious youth may present with lowered subjective health
(Ondersma, Lumley, Corlis, Tojek, & Tolia, 1997) and report
greater somatic symptoms (Crandall, Halterman, & Mackner, 2007; Hofflich, Hughes, & Kendall, 2006). Nonrecognition of physical symptoms related to anxiety symptoms may
lead to gastroenterologists attributing symptoms of anxiety to
disease activity (Walker, Gelfand, Gelfand, Creed, & Katon,
1996). In turn, medical providers may recommend unnecessary medical procedures and more aggressive medications
that may yield secondary adverse health effects that might
otherwise be averted.

Interventions for Anxiety
Psychotropic medications are widely used to treat
anxiety disorders. However, for individuals with comorbid
IBD, one of the major drawbacks of pharmacological
treatments are their physical side effects (e.g., nausea,

vomiting, upper gastrointestinal bleeding), which mirror
IBD-symptoms, and possible negative interactions with
IBD-related medications (Dalton et al., 2003; de Abajo &
Garcia-Rodriguez, 2008; Gartlehner et al., 2008).
As an alternative to medication, cognitive-behavioral
therapy (CBT) is a well-supported treatment for anxiety
disorders (Ishikawa, Okajima, Matsuoka, & Sakano, 2007;
Kendall et al., 1997; Silverman et al., 1999; Spence, Donovan,
& Brechman-Toussaint, 2000) and may be a viable (and
possibly preferred) approach for youth with co-occurring
anxiety and IBD. This approach restructures faulty cognitions to cultivate more flexible and adaptive thinking, and
utilizes exposure-based (behavioral) activities to increase
habituation to anxiety cues (Barlow, Wright, Sheasby,
Turner, & Hainsworth, 2002).

Intervening With Youth With IBD and Anxiety
Existing CBT approaches targeting clinical anxiety
disorders, however, may not be sufficient for youth with
co-occurring anxiety and IBD as they do not address the
complex interaction between emotional and physical
factors relevant to having a medical condition. For instance,
the physical symptoms associated with IBD may cause
severe pain, functional impairment, and evoke anxiety. In
some cases, the emotional distress experienced at the time
of diagnosis and subsequent disease flare-ups may generalize in-between disease exacerbation episodes. Consequently, youth may experience excessive anticipatory
anxiety of IBD symptom reoccurrence (e.g., abdominal
pain, elimination urgency), and avoid social and academic
activities during stable disease periods when such activities
are medically approved. In light of the above information,
an approach that can address the complex emotional and
physical needs found in youth with comorbid IBD and
anxiety may have clinical utility.
It is promising that the potential efficacy of an
IBD-specific tailored CBT approach has been demonstrated among youth with comorbid IBD and depression
and adults with IBD and nonclinical psychological distress.
Specifically, in a controlled study, youth who participated in
an IBD-focused CBT reported significantly fewer depressive
symptoms, more optimistic attitudes towards having IBD,
and more active coping skills posttreatment, as compared
with a nondirective comparison group (Szigethy et al.,
2007). Furthermore, youth in the IBD-focused CBT group
showed greater reductions in disease severity 6 months
following the completion of the program (Thompson,
Delaney, Flores, & Szigethy, 2011). A handful of studies
examining IBD adult samples with subclinical psychiatric
symptoms have demonstrated that cognitive behavioral
approaches were moderately successful in targeting psychological distress related to managing IBD (Boye et al.,
2011; Mussell, Böcker, Nagel, Olbrich, & Singer, 2003) and
may enhance quality of life and reduce somatic symptoms
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(Garcia-Vega & Fernandez-Rodriguez, 2004; Langhorst
et al., 2007). Yet, these approaches have not been applied
to IBD patients (youth or adults) with clinical levels of
anxiety.

One prominent issue for families with a child diagnosed
with IBD is that they may be distinctly disadvantaged with
respect to access to, and receipt of, needed mental health
services (Bennebroek Evertsz et al., 2012). Specifically, these
families (a) may have limited financial and familial resources
as a result of managing a child with chronic illness, (b) may
lack awareness of the bidirectional interactions between IBD
and mental health symptoms, and (c) may have restricted
mobility when physical symptoms of IBD are present
(Greenley et al., 2010). To address such health disparities,
providing mental health services alongside medical care in
medical settings, where children typically receive ongoing
medical treatment, may enhance access to (and receipt of)
mental health services. There is empirical support that the
integration of mental health services within medical settings
can enhance psychiatric symptom detection, increase
adherence to psychological treatment, and increase treatment outcomes among individuals with anxiety and depression (Gilbody, Bower, Fletcher, Richards, & Sutton, 2006;
Kaltman, Pauk, & Alter, 2011; Weersing, Gonzalez, Compo,
& Lucas, 2008; Weisberg, Dyck, Culpepper, & Keller, 2007).
For youth with chronic medical illnesses, the integration
of mental health services within pediatric specialty practices
in particular (e.g., gastroenterology, oncology), rather than
general pediatric settings, may provide a practical and
valuable alternative approach to increase receipt of mental
health treatment. Such a partnership could offer youth
emotional support during periods of disease symptom
exacerbation (e.g., on same day as medical treatment)
when such support is likely needed, but often too
burdensome to obtain due to physical barriers. Furthermore, a multidisciplinary, collaborative approach within a
single health-care setting may facilitate early identification of
youth who are at risk for developing more prominent
anxiety symptoms. In turn, this may lend to streamlining of
treatment services, specifically, provision of targeted psychological services that may thwart both anxiety and IBD
illness exacerbation over time.

Symptoms (TAPS; for treatment description, see Masia
Warner, Fisher, & Reigada, 2006; Reigada, Fisher, Cutler, &
Masia Warner, 2008) program. TAPS is based on Coping Cat
(Kendall, 1994), an empirically based treatment for primary
anxiety disorders in youth, and adapted to specifically target
physical symptoms associated with anxiety (without an
explanatory medical disorder) in youth (ages 8 to 17)
seeking medical care. This cognitive behavioral approach
incorporates a biopsychosocial model that emphasizes the
relationship between physical and emotional symptoms and
the ongoing monitoring of contexts in which symptoms
co-occur. Specifically, TAPS adapts cognitive and behavioral
approaches, and weekly homework assignments, to address
anxiety related to physical discomfort, and parental
involvement is achieved through three individual parent
sessions. Results from empirical studies examining TAPS
efficacy within pediatric medical settings are promising.
Reduction in anxiety and functional physical symptoms in
youth was demonstrated in a single-arm open pilot study
(Masia Warner, Reigada, Fisher, Saborsky, & Benkov, 2009)
as well as in a larger controlled trial with a 3-month follow-up
(Masia Warner et al., 2011).
TAPS + IBD consists of 13 weekly individual child
sessions with 3 independent parent sessions, and 2 monthly
child booster sessions posttreatment. All sessions are
approximately 50 minutes in duration. Similar to TAPS,
TAPS + IBD uses relaxation, cognitive restructuring, exposure, and homework exercises to target fears related to
functional physical symptoms and primary anxiety disorders (i.e., separation anxiety, social anxiety, panic disorder,
and generalized anxiety disorder). Likewise, materials are
adapted to be developmentally appropriate for two age
groups: children ages 8–12 and adolescents ages 13–17.
Importantly, TAPS + IBD expands on TAPS by including
IBD-specific materials. Additions were made to provide
(a) psychoeducation regarding disease management and
the interaction between and anxiety and IBD; (b) monitoring strategies to identify and differentiate between disease
and anxiety-related physical symptoms; (c) cognitive strategies for dealing with IBD-specific anxiety; (d) illness-related
exposures; and (e) parental support sensitive to parenting a
child with a chronic medical condition. Table 1 presents the
IBD-specific additions to the original TAPS program. These
additions and their application are described below.

Overview of TAPS + IBD: A New Treatment
Adaption to Address IBD-Specific Anxiety and
IBD Management

Psychoeducation: Comorbid IBD and Anxiety and
Disease Management

The Treatment of Anxiety and Physical Symptoms
related to IBD (TAPS + IBD) program was developed to
provide a multidisciplinary, biopsychosocial-based treatment for children and adolescents with co-occurring IBD
and anxiety within a pediatric specialty clinic. TAPS + IBD
expands on the Treatment for Anxiety and Physical

In the first session, psychoeducation about IBD and
anxiety, how they exacerbate each other, and feelings
surrounding physical illness and anxiety are reviewed. We
present three contexts in which anxiety and physical
symptoms can interact. First, feeling physical pain due to
gastrointestinal inflammation, as well as experiencing a

Access to Mental Health Services
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Table 1

IBD-Specific Content Additions to TAPS (TAPS + IBD)
Session TAPS

+ IBD

C1

Psychoeducation about physical symptoms and anxiety, how Psychoeducation about the interaction between symptoms
they exacerbate each other, and feelings surrounding anxiety of anxiety and IBD, and disease management; explore youth
feelings surrounding having a chronic physical condition
P1
Psychoeducation about physical symptoms associated with
Psychoeducation about the relationship between anxiety
anxiety, and the relationship between anxiety and pain;
and IBD; examine family responses to IBD symptoms
examine family responses to anxiety and physical symptoms;
assign relevant readings
C2
Psychoeducation about physical symptoms of anxiety;
Identify differences and overlap between emotional-related
practice relaxation techniques
physical symptoms and disease-related physical symptoms
C3
Introduction of the cognitive model; identify anxious thought
Identify IBD-related cognitions
patterns and cognitive distortions
C4
Continuation of cognitive model to examine the evidence for
Assess for hierarchy items related to illness-related fears
cognition; psychoeducation about maintaining factors of
anxiety; prepare child for in-vivo exposure; construct fear
hierarchy
P2
Focus on parental responses to anxiety and physical
Assistance navigating school and medical systems, address
complaints; encourage parents to discontinue behaviors that
parental concerns about their child’s illness, child
are maintaining anxiety; teach reinforcement principles,
independence highlighted
modeling, and other relevant skills; encourage at-home
exposure exercises and appropriate reinforcement strategies
C5
Review importance of self-praise; begin in-vivo exposures
Implement illness-related exposures if warranted
C6-C8 Continuation of exposure exercises in accordance with fear
Implement illness-related exposures if warranted
hierarchy
P3
Troubleshoot any obstacles with between-session exposures;
provide positive feedback for parent treatment adherence
C9-C12 Continuation of exposure exercises in accordance with fear
Implement illness-related exposures if warranted
hierarchy with integration of all previously reviewed skills
C13
Review of skills learned; identify warning signs and discuss
Plan for IBD symptom relapse and review disease
strategies for relapse prevention; explore termination issues
management
Note. C = Child session; P = Parent session

medical crisis and disruptions in psychosocial activities due
to IBD, can induce anxiety. Second, anxiety can exacerbate
IBD symptoms by impacting the immune system and
disease management behaviors. Third, a history of gut
inflammation (Spiller, 2007) and anxiety disorders (Campo
et al., 2004) have been linked with increased risk of physical
symptoms (including abdominal pain) not related to
disease. Accordingly, anxiety can cause pain or physical
discomfort not related to IBD inflammation by increasing
visceral hypersensitivity or pain perception (Gros, Antony,
McCabe, & Swinson, 2009). In addition, the first session
assesses disease management (e.g., medication adherence,
diet, quality of sleep) and addresses barriers to implementing healthy habits (e.g., low energy, pain, time constraints,
bathroom needs, adjustment to new diagnosis) early in the
treatment process.
Monitoring Strategies
Starting in Session 2, youth begin to identify physical
symptoms related to their disease as well as their physical
response to anxiety. Overlapping symptoms, as well as

distinctions, are discussed. Following this session, for
homework, youth record their physical discomfort,
emotional symptoms, and the context in which these
symptoms occur using the TAPS daily monitoring form.
This form has been used to assess physical symptoms
related to anxiety. In TAPS + IBD, we use this form to also
assess physical symptoms related to disease. For patients
with food-related concerns, a column for food intake is
added to the TAPS daily monitoring form. Food
sensitivities may develop when disease inflammation is
present. For example, foods high in fiber (e.g., nuts,
popcorn, seeds, cabbage, broccoli), greasy, or fatty are
commonly problematic when gastrointestinal inflammation is present and can be eliminated (Triggs et al., 2010).
On the other hand, food sensitivities can also be a
conditioned response (Baumgart & Carding, 2007), and,
when identified, avoided food should be systematically
reintegrated into the child’s diet.
At the beginning of every session, the therapist reviews
the monitoring form with the family to systematically
check in on the youth’s health status and to examine the
presences of any physical-emotional interactions over the
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week. When physical symptom are present, intervention
strategies are selected based on whether symptoms are
related to disease inflammation or triggered by emotional
contexts (Figure 1 depicts possible intervention strategies). Consultation with the patient’s treating gastroenterologist is recommended if the basis for physical
symptoms is unclear.
Addressing Illness-Related Cognitions
The TAPS + IBD program focuses on identifying,
challenging, and restructuring maladaptive thoughts related to IBD. Common anxious cognitions include fears
surrounding loss of control, reoccurrence of pain, medical
treatment and medication side-effects, disease relapse,

embarrassment, rejection by peers, low weight, and growth
delays (Calsbeek, Rijken, Bekkers, Dekker, & van Berge
Henegouwen, 2006; Graff, Walker, & Bernstein, 2009;
Sajadinejad, Asgari, Molavi, Kalantari, & Adibi, 2012). The
realistic nature of thoughts should be assessed based on
disease activity.
The TAPS + IBD program also addresses realistic
disease thoughts in the context of ongoing disease-related
issues (e.g., growth delays, medication side effects) and
disease inflammation reoccurrence (e.g., school disruptions, pain). In this case, the therapist helps the youth
generate adaptive coping cognitions (e.g., “I’ve been able
to catch up on school work before,” “While my stomach
pain sucks, I can handle it”) to balance realistic thoughts
(e.g., “I will miss several days of school,” “I am in a lot of

Figure 1. Intervention strategies for disease-related and emotional-related physical symptoms.
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pain”). Furthermore, the therapist can emphasize that
even though certain aspects of the disease cannot be
changed, thought processes and behavioral reactions can
be managed. This may help the child to gain a sense of
autonomy over his or her experience and, in turn, reduce
psychological distress.
Illness-Related Exposures
When appropriate, exposures should specifically target
excessive fears associated with IBD-specific content such as
fear of loss of bowel control, medical treatment procedures,
and embarrassment and rejection by peers. After each
exposure, the child’s anticipated negative outcomes are
compared to actual outcomes to help the child develop
realistic expectations and to facilitate his or her participation in future exercises. Exposure exercises are modified in
accordance with disease symptomatology, as it may be
contraindicated to eat certain foods or to encourage
extracurricular activities when gastrointestinal inflammation is present. However, carrying on with normal activities
when IBD symptoms are present (not severe), is typically an
important goal for the long-term functioning of children
with IBD. In the absence of empirical evidence, we caution
therapists from assuming that the presence of disease
symptoms precludes a child from participating in exposure
exercises, as such an assumption may inadvertently
reinforce the child’s avoidance. Rather, the therapist and
patient should problem-solve different situations (e.g., sit
near the bathroom/exit at restaurants and movies and
download a restroom locator application on their smartphone) and generate specific contingency plans (e.g., carry
an emergency kit of wet wipes, an extra set of underwear
and pants, and a plastic bag for soiled clothes) to increase
the child’s confidence in engaging in regular activities.
Parental Involvement
Understandably, parents of children with chronic
illnesses, such as IBD, may fear separation from their
child, worry about allowing their child to manage his or her
illness independently, and have uncertainty about the
severity of a child’s reported symptoms. As such, caregivers
may inadvertently model and reinforce an anxious coping
approach with their child (Green & Solnit, 1964; Lipstein,
2006; Pao & Bosk, 2011). The risk for parental anxiety and
problematic child-parent interactions has been evidenced
specifically among youth with IBD and their parents
(Akobeng et al., 1999; Szajnberg et al., 1993). When
indicated, therapists normalize parents’ experiences and
provide in-session psychoeducation pertaining to the
detrimental cycle of anxiety, avoidance, and dependence.
Step-wise cognitive and behavioral strategies are taught to
help parents foster their child’s independence, and
relevant readings are provided.

Parent sessions are also used to provide families with
school-related support. Parents are informed that public
schools are federally mandated to provide any child with a
chronic illness or disability with accommodations through
504 planning or individual educational plans (IEPs) to
support their child’s academic success. A handout with
common school accommodations (e.g., arrangements for
makeup assignments, homework, and exams if missed due
to IBD symptoms or hospitalizations, unlimited private
bathroom privileges, extended time on tests) is provided.
Furthermore, when physical symptoms are present,
parents may be uncertain whether to allow their child to
stay home from school. In such cases, the therapist works
with the family to create a decision tree (e.g., youth are
encouraged to go to school when mild to moderate
physical symptoms are present (5 or less on a 10-point
scale) with a “go home” contingency plan if symptoms
worsen throughout the day).

Integrating Mental Health Assessment and
Treatment (TAPS + IBD) into a Pediatric Specialty
Setting: A Pilot Collaboration Study
To assess the preliminary feasibility and the potential
benefit of our CBT program in treating comorbid anxiety
among youth with IBD, we conducted a pilot study
involving the application of the TAPS + IBD program in a
large, university-affiliated, pediatric gastroenterology
medical clinic in New York City. Several factors contributed to the successful collaborative effort necessary for
this type of multidisciplinary research endeavor. Foremost, medical staff at this practice were highly interested
to collaborate on this research project. Prior collaborative
efforts on a previous grant-funded research project on
treating anxiety and functional somatic complaints with
the current research team strengthened medical staff
buy-in regarding the importance of complementary
mental health interventions for the youths in their care.
For this study, a “basic onsite collaboration” integrative
health-care framework (as defined by Heath, Wise
Romero, & Reynolds, 2013) was employed. More specifically, consistent with this model, the study instituted
three collaborative features in the implementation of the
TAPS + IBD program: (a) a collaborative method of
identifying and referring youth with IBD and comorbid
anxiety, (b) authorized sharing of information (pertaining to
disease activity status and disease information) between
research staff and children’s treating gastroenterologists, and
(c) interdisciplinary collaborative efforts towards optimizing
treatment compliance across both specialties. In addition, a
practitioner’s office within the pediatric gastroenterology
clinic facilities was made available for provision of onsite
mental health services and separate records were maintained
by providers of differing disciplines.
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Collaborative Referrals: Identification of Anxiety in
Youth with IBD
Medical staff (i.e., gastroenterologists, nurses, and
pediatric social worker) referred youth suspected of
experiencing anxiety to our research team. To assist
medical providers in this process, research staff met with
medical staff annually to review the common symptoms of
anxiety and to rehearse (using scripts) how to introduce a
psychological treatment to families under their care. To
increase anxiety detection, parents and their children were
given an anxiety screener (Screen for Child Anxiety Related
Emotional Disorders [SCARED]; Birmaher et al., 1997) to
complete in the pediatric gastroenterology waiting room.
When elevated anxiety symptoms were detected, parents
were sent a letter by their gastroenterologist to inform them
of the TAPS + IBD program.
Authorized Sharing: Disease Activity Status and
Disease Information
Once enrolled in the study, all families signed an
authorization for release of information, which permitted
research staff to contact their children’s treating gastroenterologists to obtain current information regarding patient
disease activity. Gastroenterologists completed a validated
disease activity measure for youth in their care at pre-, post-,
and 3 months following TAPS + IBD. This measure was
used at the start of treatment to establish normative
functioning expectations (for the child and family) in the
context of youth’s health status and medical treatment. Of
equal import, medical providers were also readily available
for therapists to consult with on an as-needed basis. For
patients with IBD, medical treatment is widely heterogeneous and, like their health status, can rapidly change.
Program delivery within the gastroenterology clinic allowed
therapists greater opportunity to consult face-to-face with
gastroenterologists in order to adjust treatment to address
acute disease issues. Furthermore, in general, we found it
necessary to consult with medical providers to gain
foundational knowledge pertaining to the etiology, course,
and common medical and surgical treatments of IBD to
adequately assess and address health-related issues within a
psychological treatment.
Interdisciplinary Collaboration Towards
Treatment Compliance
Mental health and medical staff worked together to
increase treatment compliance across both specialties.
Therapists reminded families to follow through with
blood draws, and doctors reached out to families if they
missed repeated therapy sessions. This allowed therapists
and medical providers to approach IBD management
jointly (e.g., confirm medical need for school absences).
Numerous family medical obligations and distressing and

painful physical symptoms during disease exacerbation can
impede access to mental health services. Therefore, study
assessment and therapy appointments were scheduled
(when possible) to coincide with gastroenterologist appointments or Remicade infusions to reduce treatment
disruptions.

TAPS + IBD Case Examples
To elucidate applying TAPS + IBD in a medical
setting, two cases (female aged 17 years; female aged
13 years) are presented with preliminary assessment data
(see Table 2). Cases demonstrate the assessment and
treatment of IBD-specific anxiety, the importance of
consulting with treating gastroenterologists to formulate
biopsychosocial case conceptualizations and treatment
planning, the integration of illness-focused materials into
traditional CBT protocols, and the unique issues that
emerge when working with parents of children with this
medically complex condition. Case details have been
modified to protect youth identification.
The first case, Amy, illustrates the application of the
TAPS + IBD program for social anxiety disorder that
includes IBD-specific content. This particular case also
demonstrates treatment considerations when disease symptoms become exacerbated during the course of treatment
(e.g., adapting cognitive and exposure interventions,
helping youth manage physical symptoms in school). The
second case, Sasha, demonstrates how the TAPS + IBD
program was used to treat separation anxiety disorder that
included IBD-specific anxiety. Interventions were used to
address erroneous beliefs about IBD, increase awareness
and tolerance to persistent nonmedical physical symptoms,
Table 2

Preliminary Pre-, Post-, and 3-Month Follow-up Pilot Data
Self-Report

Physician
Report

SCARED

IBD-specific
Anxiety

Somatic
Symptoms

Disease
Activity

Amy
Pre
Post
3-month

34
13
12

43
32
4

8
10
6

Remission
Active
Active

Sasha
Pre
Post
3-month

36
13
7

40
11
5

36
14
15

Remission
Remission
Remission

Note. SCARED = Self-Report for Childhood Anxiety Related Disorders; IBD-specific Anxiety = Worries Specific to IBD; Somatic
Symptoms measured by the Children’s Somatization Inventory;
Disease severity measured by the Pediatric Crohn's Disease Activity
Index and Pediatric Ulcerative Colitis Activity Index. For all measures
higher scores indicate greater symptom frequency/severity.
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and improve family communication surrounding medical
decisions.
Case Recruitment and Assessments
Both Amy and Sasha reported elevated anxiety
symptoms on the anxiety screener that they completed
in the medical waiting room. Consequently, a letter was
sent from their gastroenterologist informing each family
about the research program. Amy’s family responded to
the letter. However, Sasha’s family did not contact the
research staff until 3 months later, at which time their
gastroenterologist directly (face-to-face) referred the
family.
All eligible adolescents underwent a clinical evaluation
pre-intervention, post-intervention, and 3 months after
treatment completion. Self-report data and disease activity
of the two illustrative cases are presented in Table 2.
Advanced doctoral graduate students in clinical psychology
conducted study assessments and delivered the treatment
protocol. For a given participant, assessment and treatment
were conducted by different individuals. Doctoral students
participated in a 1-day training, were provided with an
audio recording of a diagnostic interview (to test diagnostic
accuracy against the primary investigator), and watched a
video of the primary investigator delivering 13 sessions of
TAPS + IBD manual. The PI provided weekly group
supervision to review study procedures and assessments,
and weekly individual supervision to discuss treatment
progress and manual adherence.
Anxiety and depressive disorders were assessed using the
Anxiety Disorder Interview Schedule for DSM-IV—Parent
and Child Version (ADIS-P/C; Silverman & Albano, 1996).
The ADIS-P/C is a semistructured, well-established, and
reliable diagnostic tool (Lyneham, Abbott, & Rapee, 2007;
Silverman, Saavedra, & Pina, 2001). Interviewers assigned a
clinical severity rating (CSR) for each DSM-IV-TR anxiety
and depressive diagnosis. CSRs range from 0 to 8, with
ratings of 4 or higher indicating clinically significant
impairment and distress that meets the minimal criteria
for a DSM diagnosis.
IBD medical history and current IBD symptomatology
were collected to assess anxiety severity. The intensity,
frequency, and associated disruptions of IBD-specific
anxiety were assessed during both periods of disease activity
and disease remission. If IBD-specific anxiety symptoms
were related to an Axis I disorder, a specifier was assigned
(e.g., generalized anxiety disorder including IBD-specific
anxiety content).
IBD-specific anxiety was also measured using a 20-item
self-report inventory that assesses how often youth had
worried about the impact, treatment, and symptoms of
their IBD within the last 2 weeks. Items are on a 6-point
Likert scale (ranging from 0 = never to 5 = always) with

total scores ranging from 0 to 100; higher scores indicate
greater IBD-specific anxiety. Previous use of a shorter
version of this measure supports the discriminative nature
of its questions (compared with general anxiety, depression, and IBD-specific quality of life measures) and item
internal consistency (α = .94; Reigada et al., 2011). Physical
symptoms were self-reported using the Children’s Somatization Inventory (CSI; Garber, Walker, & Zeman, 1991).
This instrument was created to measure medically unexplained somatic symptoms including gastrointestinal symptoms; evidence of the instrument’s reliability and validity
has been documented with pediatric samples (Meesters,
Muris, Ghys, Reumerman, & Rooijmans, 2003). Participants’ treating gastroenterologists completed the Pediatric
Crohn’s Disease Activity Index (Hyams et al., 1991) or the
Pediatric Ulcerative Colitis Activity Index (Turner et al.,
2007), both validated instrument used to rate disease
activity.
Individual Case Evaluations and Treatment
Case 1: “Amy”
Amy was a 17-year-old Caucasian female diagnosed with
ulcerative colitis 3 years earlier by her gastroenterologist.
Amy reported moderate social anxiety symptoms which
began several years prior to the onset of her IBD (CSR = 6).
After she was diagnosed with IBD, her social concerns were
compounded by new worries that her peers would detect
her illness and notice her frequent bathroom use, especially
in the school setting. Amy avoided her anxiety in various
ways, including waking up 2 hours early to ensure a bowel
movement before school, using empty public bathrooms,
and lying about her reasons to leave the classroom. She also
feared that food (in particular dairy and greasy foods)
would trigger IBD symptoms (e.g., pain, need to urgently
use the bathroom) at school. As such, she avoided joining
her friends for lunch outings and only ate home-prepared
“safe foods.” At the preevaluation, it was revealed that Amy
had previously received psychotherapeutic treatment for
anorexia nervosa directly following her IBD diagnosis and
Prednisone use, a steroid used to treat acute IBD
inflammation symptoms that also can cause intense weight
gain. At the preevaluation for TAPS + IBD, Amy’s prior
diagnosis of anorexia was in remission for 2 years and did
not warrant clinical attention.
After Session 1, the therapist consulted with Amy’s
pediatric gastroenterologist to determine (a) if her mild
stomach pain was a symptom of disease inflammation, and
(b) if any dietary restrictions were part of her medical
management plan. Her doctor disconfirmed inflammation (based on endoscopy and inflammatory markers in
her blood) and reported that Amy could resume a normal
diet. Accordingly, the therapist added food to her daily
monitoring form (at Session 2) to further explore triggers
of Amy’s stomach discomfort and her beliefs about food.
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In Sessions 3 and 4, the therapist worked with Amy to
generate more realistic thoughts regarding her peers
evaluating her bathroom behavior negatively (e.g., “no
one will remember that I left the classroom for the
bathroom twice”) and the probability of having a bowel
accident, which was skewed by her past two accidents
(in the car) when her disease was active.
In Sessions 5 through 10, several in vivo exposure
exercises were conducted to target her fears surrounding
food triggering physical symptoms and bathroom use at
school. To address her food-related concerns, Amy
practiced eating safe and “risky” foods with her therapist.
She continued to face her fears in between sessions by
joining her friends for lunch. At first she ordered safe food,
and later in treatment, began ordering “risky” food. These
exercises, along with her physical-emotional monitoring
form, confirmed that her anxiety (rather than food)
triggered her stomach discomfort.
To target fears surrounding using public bathrooms,
Amy practiced making others wait (e.g., spending
5 minutes in a single stall bathroom) and making noise
(e.g., flushing multiple times and pouring chunky soup in
the toilet with others present) in public bathroom stalls.
At school, she practiced the same exercises. She also
excused herself from class multiple times when she did
not have to use the bathroom to confront the embarrassment associated with this behavior. Exercises disconfirmed her belief that others would notice her behavior
and that her IBD would be revealed.
The therapist met with Amy’s mother on three
occasions. In the first and second meeting, the therapist
assisted Amy’s mother to gradually transfer medical care
responsibilities to Amy. Given Amy’s age, it was developmentally appropriate to foster her independence. Yet,
Amy’s mother reported that she managed her daughter’s
disease (e.g., repeatedly reminded Amy to take her
medications, selected her nightly meals, and made all
preparations for outings and trips) and frequently inquired
about her daughter’s health. These behaviors contributed
to Amy’s sense of feeling “disabled” and triggered her
IBD-specific anxiety.
At Session 10, Amy’s IBD symptoms reoccurred
(referred to as a disease flare-up). Accordingly, the third
parent session and remaining child sessions were dedicated
to providing disease management support (e.g., clean set of
clothes left with the nurse in the event that an accident
occurred) while Amy continued to attend school and
participate in social activities. Given her change in health
status, eating “risky” foods was no longer recommended
and, instead, Amy went out to lunch with friends but with a
packed lunch. Additionally, in session, Amy wrote down
coping statements (e.g., “I have reached the bathroom in
the past at school”) on an index card to remind herself
when anxious. In the last parent session, the therapist

worked with Amy’s mother to ensure that the appropriate
school personnel were informed of Amy’s disease status
change and that the appropriate accommodations were in
place at school. Of note, after the 12th session Amy had an
urgent bowel emergency at school while with her peers
(a situation at the top of her fear hierarchy). This incident
was not noticed by her peers and, as a result, Amy no longer
worried about using the bathroom at school.
Immediately following treatment, despite the presence of
active IBD symptoms (physician confirmed), Amy reported
no bathroom-related fears and she continued to attend
school and go out to lunch with her friends. Even though
Amy showed some treatment gains, she continued to exhibit
mild social anxiety disorder (CSR = 4). Three months
following treatment termination, Amy no longer met
diagnostic criteria for social anxiety disorder (subthreshold
CSR = 2). Furthermore, she reported almost no IBD-related
anxiety, despite her ongoing challenges with IBD symptoms
over the last 3 months, which had caused significant physical
distress and resulted in 2 months of school absences.
Impressively, during this time, Amy had returned to school
without any setbacks in her overall functioning.

Case 2: “Sasha”
Sasha was a 13-year-old Caucasian female diagnosed
with Crohn’s disease at age 10. Since infancy, Sasha
suffered from digestive problems, and she displayed
significant distress when separated from her mother,
especially at home or when going to sleep. Sasha’s mother
found it extremely difficult to tolerate her daughter’s
distress when she was in physical discomfort; as such, she
would stay with her daughter throughout the night. At the
age of 8, Sasha participated in exposure therapy with a
private practitioner. According to Sasha, treatment
focused on her fear of a possible intruder but dismissed
her anxiety pertaining to the reoccurrence of physical
symptoms (e.g., nausea). Both fears contributed to her
avoidance of sleeping alone at night; as such, treatment
was perceived as distressing and unhelpful.
Two years later, Sasha’s diagnosis of Crohn’s disease
largely confirmed her fear that something was “wrong” with
her physically and reinforced that her mother needed to
stay with her at night in case her disease worsened and
required immediate medical attention. At the time of the
preassessment, Sasha worried daily about physical symptoms (abdominal pain, migraines, and nausea) that she
experienced regularly, which she attributed to her Crohn’s
disease. In contrast, her gastroenterologist reported that
the surgical removal of part of her intestines had
successfully eliminated gastrointestinal inflammation
(confirmed by endoscopy and inflammatory markers in
her blood). Additionally, she avoided being home alone,
day trips with friends, sleepovers, and even family vacations.

Collaborating with Pediatric Gastroenterologists
Sasha therefore received a diagnosis of separation anxiety
disorder, including IBD-specific anxiety (CSR = 6).
In addition to her separation concerns, Sasha also
avoided talking to new people (e.g., peers, store clerks) and
revealing her IBD-related surgery scars. She met the criteria
for mild social anxiety disorder including IBD-specific
anxiety (CSR = 4). Of note, within the last year Sasha began
experiencing symptoms of mild major depression (CSR =
4), which was strongly suspected to be a secondary response
to her impairing severe anxiety symptoms. From this
conceptualization, treating her anxiety was expected to
secondarily reduce her depressive symptoms. Thus, it was
deemed clinically appropriate to proceed with the
TAPS + IBD program with ongoing monitoring of depressive symptoms.
At the start of treatment, Sasha was initially reluctant
to work on separation fears; therefore, initial cognitive
and behavioral interventions focused on her social
anxiety. However, by Session 5, she began to consider
that her nighttime physical symptoms may be related to
anxiety given the consistent data collected daily using
the physical-emotional monitoring form. Once this
connection was identified, Sasha was able to start to
challenge her anxious thought (“My stomach hurts
because of IBD, which means it’s getting worse”) and
consider a new, more balanced alternative thoughts
(“My stomach hurts but it’s not going to keep me from
having a good night!”).
Before participating in night-time exposures, it became
evident that a family systemic factor was maintaining
Sasha’s anxiety. Approximately twice a month, Sasha’s
mother took her to the hospital to assess the seriousness of
her physical symptoms (even though these visits were always
unwarranted based on Sasha’s medical status). To address
this, the therapist had the family create a hospital
decision-tree with their gastroenterologist. Based on
Sasha’s current disease activity, the plan outlined four
specific situations that would require an immediate hospital
visit: (a) the doctor prescribes it, (b) vomiting or diarrhea
accompanied by bloody stool and dehydration, (c) severe
head pain accompanied by blurred vision, and (d) acute
onset of abdominal pain accompanied by fever, visible
thickening of the abdomen, and/or inability to use the
bathroom for more than 2 days. Creating a plan helped the
family assess the severity of physical symptoms and respond
accordingly based on their doctor’s recommendations. By
Session 6, Sasha agreed to sleep without her mother even
when physical symptoms were present.
Another notable treatment milestone included psychoeducation regarding the nonfatal nature of IBD, which
countered Sasha’s long-held secret belief that she was going
to die from IBD symptoms suddenly during the night (this
was revealed in Session 9). Prior to this session, Sasha had
slept alone approximately 3 nights per week, had gone on

one sleepover, and on a 2-night school-related trip without
her mother. Following this session, Sasha was able to
sleep alone for the remainder of the program (4 weeks).
She even implemented exposures on her own at night
(e.g., danced around in an attempt to induce physical
symptoms).
The therapist had two one-on-one sessions with Sasha’s
mother and one session with both of Sasha’s parents. In
addition to helping Sasha’s mother create a reward system
for sleeping alone at night, the therapist also helped
Sasha’s mother challenge her beliefs about her daughter’s physical symptoms (e.g., “If I do not comfort her, the
stress will bring back her IBD”). By the second parent
session, using data from the physical-emotional monitoring form, along with consulting with their gastroenterologist (e.g., creating an emergency plan and confirmation
that Sasha’s physical symptoms were not related to IBD
inflammation), Sasha’s mother was able to verbalize, “My
daughter is learning how to handle her physical
symptoms, which will help her throughout life.” The last
parent session focused on helping both parents to agree
on a parenting plan when Sasha’s physical symptoms were
present so that they could provide a unified, consistent
message.
At the end of treatment, Sasha no longer met criteria for
separation or social anxiety (CSRs of 2 and 1, respectively).
Her IBD-related anxiety was greatly reduced, and she
reported a significant reduction in physical symptoms. The
latter is noteworthy, as her disease status and medical
treatment remained the same throughout the program. At
the time of the postassessment, Sasha was sleeping alone
every night and attended several sleep-away events with
friends. Lastly, confirming our hypothesis, her depression
(CSR = 0) also remitted as a result of addressing her anxiety
symptoms.
Three months later, Sasha continued to maintain
treatment gains pertaining to her separation anxiety,
depression, and physical symptoms. Her social anxiety
symptom reoccurred, but symptoms were circumscribed
to her recent transition to a new high school (CSR = 4).
Given their newfound success with the current program,
Sasha and her mother decided to seek out additional CBT
therapy to address these issues.

Treatment Implementation Obstacles and IBD
Specific Issues
Several implementation issues emerged while conducting this pilot program within the medical setting and with
youth with comorbid anxiety and IBD. Below, we describe
the challenges of TAPS + IBD pertaining to detection of
anxiety within the medical setting, issues relevant to
selecting behavioral exposures sensitive to IBD, and unique
parental considerations.
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Anxiety Detection and Referral Within the
Medical Setting
As the program unfolded, we noted that our anxiety
identification and the treatment referral process was
limited. While anxiety detection using a waiting room
anxiety questionnaire was seemingly sensitive, with 34% of
youngsters (N = 46/135) identified as having elevated
anxiety symptoms, less than 1% of families who received a
letter from their gastroenterologist (informing them of a
no-cost mental health service provided on-site) contacted
our research staff. In contrast, 6 out of the 11 families (over
50%) directly referred by medical staff (face-to-face)
initiated contact with our research staff. Although direct
doctor referrals were most effective, medical staff were
inconsistent in discussing mental health issues with their
patients, despite mental health awareness among collaborating gastroenterologists. Furthermore, direct doctor
referrals yielded mostly moderate to severe anxiety cases.
These excluded less severe clinical anxiety cases that are
associated with functional disability and which may respond
to early intervention optimally.
Possible explanations are that the identification of
milder, clinical anxiety cases may be difficult to identify,
necessitate extra time to assess, and require more in-depth
knowledge about anxiety (Steele, Lochrie, & Roberts, 2010).
Moreover, there may be a general misconception by the
medical field that mild anxiety symptoms and IBD-specific
anxiety do not require additional attention beyond medical
treatment for IBD (Benhayon & Szigethy, 2013). In
addition, doctor incentive to assess mental health well-being
and to initiate patient referral was possibly low given that our
program was an “add-on” research service that was managed
separately from the clinic’s standard medical practice and
not associated with department revenues. While this “half-step” method of integration can provide a valuable
approximation to real-world care (Weersing et al., 2008),
this approach is limited with respect to application in (some)
real-world (nonresearch) practice settings. Efforts aimed at
exploring different levels of integrated health-care practice
models, and assessment and treatment delivery models (e.g.,
medical staff delivered mental health programs) require
further empirical examination to establish the feasibility and
sustainability of program implementation.
Disease Sensitive Behavioral Exposures
Another consideration when working with youth with
comorbid anxiety and IBD is that exposures may need to be
adapted when IBD symptoms reoccur. During these times
anxiety symptoms (disease and non-disease specific) may
become more prominent and certain exercises may be
clinically counterindicated (e.g., as demonstrated in Amy’s
case). Additionally, IBD-related symptoms, such as reduced
energy levels, can emerge during active disease phases or

after the administration of certain medical interventions
(e.g., Remicade infusion). In such cases, creating brief
exposure exercises sensitive to the possibility of fatigue may
be necessary.
Addressing Parental Issues
Working with the parents of youth with IBD and anxiety
also reveals factors for consideration when intervening with
this population. In both case examples, the anxiety
experienced by participants’ mothers contributed to their
daughters’ dependent behaviors. These parents may
require assistance in accurately evaluating their fears
about the health of their child, differentiating anxiety
symptoms from disease symptoms, encouraging brave
behaviors even when their child is symptomatic, and
understanding the overall importance of allowing their
child to manage some of their disease care independently
when developmentally appropriate. These facets of parent-focused treatment differ from typical anxiety-related
parent training and may be crucial in helping families
affected by IBD make progress in anxiety treatment.

Blueprint for the Future
As illustrated by our case examples, medical settings may
play an important role in the identification of anxiety and
provision of specially tailored mental health services in
tandem with medical interventions in the treatment of
youth with chronic physical conditions. Further empirical
validation of new delivery models where medical and
mental health issues are simultaneously addressed is
needed. For instance, integration of CBT as a “complementary medicine” holds promise towards the possible
facilitation of early identification of youth at risk for more
anxiety (illness-specific and other anxiety). Over time,
efficacious, multidisciplinary, team-based treatment approaches within standard medical care settings may not
only increase convenience and accessibility of treatment,
but also have the potential to reduce stigma, increase family
participation in (and in turn the efficacy of) mental health
service delivery, and reduce economic and emotional
burdens incurred by affected families and the broader
health-care system.
The cases also highlight the value of therapists
collaborating with medical providers to obtain objective
and current information regarding a child’s disease activity
and to establish normative functioning expectations in the
context of symptom presentation and medical treatment.
Based on anecdotal information, we found that addressing
IBD symptom reoccurrence and disease management,
along with associated emotional distress, was a critical
therapeutic aim when working with this population.
However, further consideration of whether addressing
these factors are necessary to optimally treat youth with
comorbid physical and emotional symptoms is needed.

Collaborating with Pediatric Gastroenterologists
The work described in this paper also illustrates the
potential significance of cross-discipline education. Working with medical staff, therapists can gain a better
understanding of the etiology and disease course of IBD,
as well as common treatments and surgeries. In turn, the
medical treatment team may become more aware of mental
health sequelae of, and contributions to, IBD.
Further scientific inquiry focused on CBT effects on
disease and other physiological outcomes, and on prospective long-term follow-up to examine the sustainability of
treatment gains, is needed. Along this line, our research
team is currently implementing a randomized control trial
in which TAPS + IBD is compared to a nondirective
treatment among youth. Equally important, we encourage
the integration of health issues into research and practice
with a broader range of medical and comorbid psychiatric
health issues. For instance, youth with chronic physical
symptoms seem to be particularly vulnerable to developing
anxiety and depression (Katon, Richardson, Lozano, &
McCauley, 2004; Kovacs, Goldston, Obrosky, & Bonar,
1997), and in general, comorbity among anxiety and
depressive disorders is common (Axelson & Birmaher,
2001; Birmaher et al., 1996; Brady & Kendall, 1992). In light
of these findings, integrating health issues into transdiagnostic or unified protocols (Ehrenreich-May & Bilek, 2012)
that can target both anxiety and depressive symptoms
(along with disease-related emotional and physical responses) may have particular clinical utility for youth with
chronic illness. More broadly, integrative interventions that
equip adolescents with coping skills in the early stages of
illness may better enable youth to manage their disease.
This, in turn, may ameliorate anxiety and physical
symptoms and possibly thwart medical illness progression.
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